ArticleBMC cardiovascular disorders2025
Machine learning for classification of advanced rheumatic heart disease using electrocardiogram in cardiology ward.
Article in BMC cardiovascular disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundRheumatic heart disease (RHD) arises from untreated streptococcal throat infections caused by beta-hemolytic group A streptococci, leading to progressive damage to cardiac valves. While echocardiography is the gold standard for RHD diagnosis, its use in low-income countries is limited due to scarce resources and a lack of trained professionals. Automated RHD detection via echocardiography and phonocardiography data has shown promising, but the effectiveness of electrocardiogram (ECG) for detecting RHD in endemic regions at cardiac wards with limited resource remains uncertain. This study explores the viability of ECG as a cost-effective tool for RHD detection in cardiac wards.
methodsThe study utilizes a dataset comprising single-lead ECG recordings from 124 confirmed RHD patients and 46 healthy controls collected at a major referral hospital in Ethiopia. Additionally, an extended-RHDECG dataset, which consists of age-matched ECGs from the Physikalisch-Technische Bundesanstalt (PTB-XL) dataset and RHD ECGs, was utilized. A single lead ECG segment of 10-second duration per patient was resampled at 250 Hz. Temporal and relative wavelet energy (RWE) features combined with Convolutional Neural Network (CNN) model features were employed for classification of prevalent cardiovascular diseases in the context of the Global South.
resultsA 5-folds cross-validation on RHDECG dataset using CNN model showed an average accuracy (mean ± std) of 88.6 ± 0.2% in detecting RHD from healthy controls. This result was improved with combined features of CNN, temporal and RWE to an average accuracy of 94.6 ± 0.1%. Similar evaluation on extended-RHDECG yielded an accuracy of 54.3 ± 0.3%, which reached to 71.2 ± 0.3% considering the top-2 predictions of the six classes. The RWE concentrations at higher frequency bands were significantly greater in the RHD group than in the healthy control group.
conclusionThe findings suggest that single-lead ECG in combination with machine learning could serve as a potential tool for automatically classifying patients with advanced RHD. ECG time‒frequency features effectively capture abnormalities associated with RHD, enhancing the performance of deep CNN models. This approach offers a cost-effective tool that might be useful in addressing the RHD burden at resource-constrained cardiac clinics in alignment with global health development goals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.